Global VCs Gather at MedTEX Summit Asia 2023 to Scout Next Biotech Breakthroughs

Taipei, Taiwan — The 6th MedTEX Summit Asia, jointly hosted by the Development Center for Biotechnology (DCB) and Everbright Biotech Ventures, took place on December 4, 2023, during the Healthcare+ Expo Taiwan. The summit drew over 500 attendees, including leading international venture capital firms, emerging biotech startups, and global technology leaders, creating a vibrant platform for cross-sectoral dialogue and collaboration.

Global Biotech Capital Flocks to Taiwan

Top global VC firms including B Capital, Insight Partners, ARCH Venture Partners, Flare Capital, Playground Global, and Vive Collective gathered at the summit to share insights on emerging biotech trends, capital deployment strategies, and collaborative models.

Panel discussions emphasized the rising importance of Asia as a key driver of biotech innovation, with Taiwan’s agile regulatory environment, solid manufacturing base, and maturing startup ecosystem making it an attractive launchpad for international ventures seeking Asia-Pacific expansion.

廣達電腦林百里董事長指出人類正迎接 AI 新世代的黎明,並鼓勵醫療人員積極參與醫用 AI 的開發與落地實踐。(圖片來源:基因線上)

 

15 Global Startups Make Their Debut in Taiwan

This year marked the launch of the “International Startup Pitch Showcase”, featuring 15 cutting-edge startups from the U.S., Singapore, and Europe. These included:

  • Arbor Biotechnologies (CRISPR-based therapeutics, USA)

  • Tempo Therapeutics (wound healing biomaterials, USA)

  • ImmuneBridge (next-gen cell therapy, USA)

  • Qritive (AI-powered pathology, Singapore)

  • HistoSonics (non-invasive tumor ablation, USA)

These startups are active in areas such as cell therapy, digital pathology, neurology, gene editing, and regenerative medicine. Through pitch sessions and networking activities, they explored opportunities for funding and partnerships with Taiwan-based investors and ecosystem players.

Taiwan Positioned as a Strategic Biotech Bridge

The MedTEX Summit illustrated how biotech and healthcare are at the intersection of capital, innovation, and policy, and how Taiwan can play a key role in connecting East and West. From AI drug discovery to advanced diagnostics and precision health, international participants expressed keen interest in leveraging Taiwan’s capabilities for clinical research, technology development, and market access.

Contact
MedTEX Summit Asia Organizing Team
Email: info@taiwan-healthcare.org
Website: expo.taiwan-healthcare.org

Copyright © 2025 Everbright Biofund